Ricin A-Chain Activity on Stem−Loop and Unstructured DNA Substrates
- 25 February 2005
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 44 (11) , 4416-4425
- https://doi.org/10.1021/bi0474362
Abstract
Ricin toxin A-chain (RTA) depurinates a single adenylate on a GAGA stem-loop region of eukaryotic 28S RNA, making it a potent toxin. Steady state rate analysis is used to establish the kinetic parameters for depurination of short RNA, DNA, and RNA-DNA hybrids of GAGA linear segments and stem-loop regions as substrates for RTA. Both stem and tetraloop structures are essential for action on RNA. For DNA stem-loop substrates, stem stability plays a small role in enhancing catalytic turnover but can enhance binding by up to 3 orders of magnitude. DNA sequences of d[GAGA] without stem-loop structures are found to be slow substrates for RTA. In contrast, equivalent RNA sequences exhibit no activity with RTA. Introduction of a deoxyadenosine at the depurination site of short RNA oligonucleotides restores catalytic function. NMR analysis indicates that the short, nonsubstrate GAGA is converted to substrate in GdAGA by the presence of a more flexible ribosyl group at the deoxyadenosine site. Conversion between C2'-endo and C2'-exo conformations at the deoxyadenosine site moves the 3'- and 5'-phosphorus atoms by 1.1 A, and the former is proposed to place them in a catalytically favorable configuration. The ability to use short RNA-DNA hybrids as substrates for RTA permits exploration of related structures to function as substrates and inhibitors.Keywords
This publication has 14 references indexed in Scilit:
- Crystal structure of Trypanosoma cruzi glyceraldehyde‐3‐phosphate dehydrogenase complexed with an analogue of 1,3‐bisphospho‐d‐glyceric acidEuropean Journal of Biochemistry, 2003
- V(D)J Recombination: RAG Proteins, Repair Factors, and RegulationAnnual Review of Biochemistry, 2002
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Polynucleotide: Adenosine Glycosidase Activity of Immunotoxins Containing Ribosome-Inactivating ProteinsJournal of Drug Targeting, 2000
- The two faces of the Escherichia coli 23 S rRNA sarcin/ricin domain: the structure at 1.11 Å resolutionJournal of Molecular Biology, 1999
- A Network of Heterogeneous Hydrogen Bonds in GNRA TetraloopsJournal of Molecular Biology, 1996
- Stabilization of mRNA in an Escherichia coli cell‐free translation systemFEBS Letters, 1993
- Ribosomal RNA identity elements for ricin A-chain recognition and catalysisJournal of Molecular Biology, 1992
- Immunotoxins: New therapeutic reagents for autoimmunity, cancer, and AIDSJournal of Clinical Immunology, 1990
- Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomesBiochemical Journal, 1975